estrone has been researched along with Atypical Endometrial Hyperplasia in 28 studies
Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.
Atypical Endometrial Hyperplasia: A benign form of endometrial hyperplasia with increased number of cells with atypia. The atypical cells are large and irregular and have an increased nuclear/cytoplasmic ratio. The risk of progression to endometrial carcinoma rises with the increasing degree of cell atypia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A regime of cyproterone acetate (CPA) (300 mg/day by the oral route for 30 days) has been used in 10 post-menopausal women with endometrial hyperplasia (8 atypical and 2 adenomatous)." | 7.67 | Treatment of endometrial hyperplasia with cyproterone acetate histological and hormonal aspects. ( Bulletti, C; Ciotti, P; Flamigni, C; Franceschetti, F; Jasonni, VM; Marabini, A; Naldi, S; Vignudelli, A, 1986) |
| "Plasma androstenedione (A) levels and plasma oestrone (E1) levels were measured by radioimmunoassay in a total of 135 healthy women (the control group), around the menopause." | 7.66 | Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium. ( Battaglia, F; Mango, D; Montemurro, A; Scirpa, P; Scirpa, S, 1982) |
| " Ten patients with histologically proven endometrial hyperplasia were treated with Danazol at a dosage of 600 mg/day for 30 days." | 5.27 | Preliminary report on postmenopausal endometrial hyperplasia treatment with Danazol: histological and endocrinological aspects. ( Bulletti, C; Ciotti, P; Flamigni, C; Jasonni, VM; La Marca, L; Naldi, S; Vignudelli, A, 1986) |
| "A regime of cyproterone acetate (CPA) (300 mg/day by the oral route for 30 days) has been used in 10 post-menopausal women with endometrial hyperplasia (8 atypical and 2 adenomatous)." | 3.67 | Treatment of endometrial hyperplasia with cyproterone acetate histological and hormonal aspects. ( Bulletti, C; Ciotti, P; Flamigni, C; Franceschetti, F; Jasonni, VM; Marabini, A; Naldi, S; Vignudelli, A, 1986) |
| "Plasma androstenedione (A) levels and plasma oestrone (E1) levels were measured by radioimmunoassay in a total of 135 healthy women (the control group), around the menopause." | 3.66 | Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium. ( Battaglia, F; Mango, D; Montemurro, A; Scirpa, P; Scirpa, S, 1982) |
| " Ten patients with histologically proven endometrial hyperplasia were treated with Danazol at a dosage of 600 mg/day for 30 days." | 1.27 | Preliminary report on postmenopausal endometrial hyperplasia treatment with Danazol: histological and endocrinological aspects. ( Bulletti, C; Ciotti, P; Flamigni, C; Jasonni, VM; La Marca, L; Naldi, S; Vignudelli, A, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (78.57) | 18.7374 |
| 1990's | 2 (7.14) | 18.2507 |
| 2000's | 3 (10.71) | 29.6817 |
| 2010's | 1 (3.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lobo, RA | 1 |
| Liu, J | 1 |
| Stanczyk, FZ | 1 |
| Constantine, GD | 1 |
| Pickar, JH | 2 |
| Shadiack, AM | 1 |
| Bernick, B | 1 |
| Mirkin, S | 1 |
| Bochkareva, NV | 1 |
| Kolomiets, LA | 1 |
| Kondakova, IV | 1 |
| Stukanov, SL | 1 |
| Tropina, TV | 1 |
| Muntian, AB | 1 |
| POLISHUK, WZ | 1 |
| PLUNKETT, ER | 1 |
| KASE, N | 1 |
| Deng, L | 1 |
| Broaddus, RR | 1 |
| McCampbell, A | 1 |
| Shipley, GL | 1 |
| Loose, DS | 1 |
| Stancel, GM | 1 |
| Davies, PJ | 1 |
| Goldzieher, JW | 1 |
| Fariss, B | 1 |
| Prost, O | 1 |
| Adessi, GL | 1 |
| Pelusi, G | 1 |
| Moretti, B | 1 |
| Martinelli, G | 1 |
| Camerini, T | 1 |
| Busacchi, P | 1 |
| Cavallina, R | 1 |
| Kasai, T | 1 |
| Takeda, B | 1 |
| Takamizawa, H | 1 |
| Scirpa, P | 1 |
| Mango, D | 1 |
| Battaglia, F | 1 |
| Scirpa, S | 1 |
| Montemurro, A | 1 |
| Forney, JP | 1 |
| Milewich, L | 1 |
| Chen, GT | 1 |
| Garlock, JL | 1 |
| Schwarz, BE | 1 |
| Edman, CD | 2 |
| MacDonald, PC | 2 |
| James, VH | 2 |
| Reed, MJ | 2 |
| Folkerd, EJ | 1 |
| Klemi, PJ | 1 |
| Grönroos, M | 1 |
| Rauramo, L | 1 |
| Punnonen, R | 1 |
| Niwa, K | 1 |
| Murase, T | 1 |
| Furui, T | 1 |
| Morishita, S | 1 |
| Mori, H | 2 |
| Tanaka, T | 1 |
| Tamaya, T | 1 |
| Rebar, RW | 1 |
| Trabal, J | 1 |
| Mortola, J | 1 |
| Whitehead, MI | 2 |
| Badawy, SZ | 1 |
| Elliott, LJ | 1 |
| Elbadawi, A | 1 |
| Marshall, LD | 1 |
| Grodin, JM | 1 |
| Vellios, F | 1 |
| Siiteri, PK | 1 |
| Brush, MG | 1 |
| Milton, PJ | 1 |
| Swain, M | 1 |
| Moore, J | 1 |
| Harris, ST | 1 |
| Genant, HK | 1 |
| Baylink, DJ | 1 |
| Gallagher, JC | 1 |
| Karp, SK | 1 |
| McConnell, MA | 1 |
| Green, EM | 1 |
| Stoll, RW | 1 |
| Jasonni, VM | 3 |
| Franceschetti, F | 1 |
| Ciotti, P | 3 |
| Bulletti, C | 3 |
| Vignudelli, A | 2 |
| Marabini, A | 1 |
| Naldi, S | 2 |
| Flamigni, C | 3 |
| Tabanelli, S | 1 |
| Cappuccini, F | 1 |
| Borini, A | 1 |
| La Marca, L | 1 |
| Beranek, PA | 1 |
| Ghilchik, MW | 1 |
| Rader, MD | 1 |
| Flickinger, GL | 1 |
| DeVilla, GO | 1 |
| Mikuta, JJ | 1 |
| Mikhail, G | 1 |
| Markovski, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Aromatase Inhibitors: Skeletal Effects and the Role of CYP19 Gene Polymorphisms[NCT00603967] | 151 participants (Actual) | Interventional | 2006-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for estrone and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules).
Topics: Adult; Aged; Biological Availability; Endometrial Hyperplasia; Estradiol; Estrone; Female; Hot Flash | 2019 |
Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer.
Topics: Adenocarcinoma; Biomarkers, Tumor; Case-Control Studies; Endometrial Hyperplasia; Endometrial Neopla | 2005 |
Low-dose esterified estrogens (0.3 mg/day): long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women.
Topics: Double-Blind Method; Endometrial Hyperplasia; Equilin; Estrogen Replacement Therapy; Estrone; Female | 2000 |
The effects of estrone (Ogen) on spinal bone density of postmenopausal women.
Topics: Bone Density; Dose-Response Relationship, Drug; Double-Blind Method; Endometrial Hyperplasia; Estron | 1991 |
24 other studies available for estrone and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
[Sex hormones in the systemic and local circulation in endometrial hyperplasia and neoplasia: correlation with the activity of estrogen-metabolizing enzymes].
Topics: Androstenedione; Aromatase; Endometrial Hyperplasia; Endometrial Neoplasms; Estradiol; Estrone; Fema | 2008 |
A case of pyometra due to prolonged oestrone administration.
Topics: Endometrial Hyperplasia; Estrone; Female; Humans; Pyometra; Suppuration; Uterus | 1963 |
DRUGS FOR FUNCTIONAL UTERINE BLEEDING.
Topics: Contraceptive Agents; Contraceptives, Oral; Diethylstilbestrol; Dosage Forms; Drug Therapy; Dydroges | 1964 |
STEROID SYNTHESIS IN ABNORMAL OVARIES. II. GRANULOSA CELL TUMOR.
Topics: Androgens; Chromatography; Corpus Luteum Hormones; Dehydroepiandrosterone; Endometrial Hyperplasia; | 1964 |
The polycystic ovary. VII. Intractable uterine bleeding and endometrial hyperplasia possibly related to an extraovarian source of oestrogen.
Topics: 17-Ketosteroids; Adrenal Glands; Adult; Androgens; Chromatography; Cysts; Endometrial Hyperplasia; E | 1967 |
Estrone and dehydroepiandrosterone sulfatase activities in normal and pathological human endometrium biopsies.
Topics: Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Endometrial Hyperplasia; Endometrium; Estron | 1983 |
Behavior of some steroids in endometrial adenomatous and atypical hyperplasia.
Topics: Adult; Androgens; Androstenedione; Dehydroepiandrosterone; Endometrial Hyperplasia; Estradiol; Estro | 1983 |
[Studies on the early diagnosis of endometrial carcinoma. Analysis of risk factors and cytological approach].
Topics: Adult; Aged; Cytodiagnosis; Endometrial Hyperplasia; Estrone; Female; Humans; Menopause; Middle Aged | 1984 |
Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aging; Androstenedione; Endometrial Hyperplasia; Estrone; F | 1982 |
Aromatization of androstenedione to estrone by human adipose tissue in vitro. Correlation with adipose tissue mass, age, and endometrial neoplasia.
Topics: Adipose Tissue; Adult; Aged; Aging; Androstenedione; Aromatase; Endometrial Hyperplasia; Estrone; Fe | 1981 |
Studies of oestrogen metabolism in postmenopausal women with cancer.
Topics: Adipose Tissue; Aged; Androstenedione; Body Weight; Breast Neoplasms; Endometrial Hyperplasia; Estra | 1981 |
Ultrastructural features of endometrial atypical adenomatous hyperplasia and adenocarcinomas and the plasma level of estrogens.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Endometrial Hyperplasia; Estradiol; Estriol; Estroge | 1980 |
Enhancing effects of estrogens on endometrial carcinogenesis initiated by N-methyl-N-nitrosourea in ICR mice.
Topics: Adenocarcinoma; Animals; Endometrial Hyperplasia; Endometrial Neoplasms; Estradiol; Estriol; Estrone | 1993 |
The effects of oestrogens and progestogens on the postmenopausal endometrium.
Topics: Endometrial Hyperplasia; Endometrium; Estrogens; Estrone; Female; Humans; Menopause; Menstruation; M | 1978 |
Plasma levels of oestrone and oestradiol-17beta in postmenopausal women.
Topics: Adult; Age Factors; Aged; Body Weight; Endometrial Hyperplasia; Estradiol; Estrogens; Estrone; Femal | 1979 |
Origin of estrogen in a postmenopausal woman with a nonendocrine tumor of the ovary and endometrial hyperplasia.
Topics: Androgens; Androstenedione; Castration; Cystadenoma; Endometrial Hyperplasia; Estrogens; Estrone; Fe | 1976 |
Proceedings: Endocrine factors in the aetiology of cystic hyperplasia of endometrium.
Topics: Adult; Cysts; Endometrial Hyperplasia; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating H | 1975 |
Treatment of endometrial hyperplasia with cyproterone acetate histological and hormonal aspects.
Topics: Androgen Antagonists; Androstenedione; Cyproterone; Cyproterone Acetate; Endometrial Hyperplasia; Es | 1986 |
Prevention of endometrial abnormalities.
Topics: Endometrial Hyperplasia; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female | 1986 |
Increased extraction of estrogens in human endometrial hyperplasia and carcinoma.
Topics: Adenocarcinoma; Endometrial Hyperplasia; Endometrium; Estradiol; Estrone; Female; Humans; Perfusion; | 1988 |
Preliminary report on postmenopausal endometrial hyperplasia treatment with Danazol: histological and endocrinological aspects.
Topics: Danazol; Endometrial Hyperplasia; Estrone; Female; Humans; Menopause; Middle Aged; Pregnadienes | 1986 |
Estrogen production and metabolism in normal postmenopausal women and postmenopausal women with breast or endometrial cancer.
Topics: Aged; Body Weight; Breast Neoplasms; Endometrial Hyperplasia; Estradiol; Estrone; Female; Humans; Me | 1986 |
Plasma estrogens in postmenopausal women.
Topics: Adult; Age Factors; Aged; Body Weight; Castration; Diabetes Mellitus; Endometrial Hyperplasia; Endom | 1973 |
[Results of treatment of juvenile hemorrhagic metropathy with the authors method of hormone therapy, consisting of a combination of estrogen and progesterone].
Topics: Curettage; Drug Synergism; Endometrial Hyperplasia; Estrone; Female; Humans; Menorrhagia; Metrorrhag | 1973 |